HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wellness (Dietary Supplements)

Set Alert for Wellness

Regulation / Legislation Explore this Topic

Set Alert for Regulation and Legislation {Wellness}

Latest From Regulation & Wellness

Urged By US FDA To Boost Infant Formula Supply, Additional Providers Still Must Wait For Approval

Patricia Hansen, CFSAN’s Office of Nutrition and Food Labeling deputy director and John Verbeten, deputy director for Import Operations Enforcement laid out the FDA's new enforcement guidance, and urged businesses with available formula to wait for approval before distributing formula in the US.

FDA Guidance Documents

House Appropriators Sound Off During FDA Hearing About Formula, More Consumer Health Issues

Before Agriculture/FDA subcommittee about FY2023 budget, Commissioner Robert Califf says FDA needs more resources to address unlisted fragrances in menstrual products and doesn’t have good regulatory options for hemp and kratom. His formula emergency comments leave members frustrated.

FDA Policy

Sweden Proposes Maximum Levels For Vitamin D And Iodine In Supplements

Concerned about adverse health effects, Sweden wants to limit the amount of vitamin D and iodine in supplements from January 2024. In setting maximum levels for certain vitamins and minerals, Sweden will join a host of European countries introducing national rules in the absence of direction from the European Commission. 

Sweden Regulation
See All

Latest From Legislation & Wellness

House Appropriators Sound Off During FDA Hearing About Formula, More Consumer Health Issues

Before Agriculture/FDA subcommittee about FY2023 budget, Commissioner Robert Califf says FDA needs more resources to address unlisted fragrances in menstrual products and doesn’t have good regulatory options for hemp and kratom. His formula emergency comments leave members frustrated.

FDA Policy

Sweden Proposes Maximum Levels For Vitamin D And Iodine In Supplements

Concerned about adverse health effects, Sweden wants to limit the amount of vitamin D and iodine in supplements from January 2024. In setting maximum levels for certain vitamins and minerals, Sweden will join a host of European countries introducing national rules in the absence of direction from the European Commission. 

Sweden Regulation

Biden Mandates Prioritizing Supplies For Infant Formula Production Over All Other Uses

Democrats and Republicans vote to approve $28m emergency finding for FDA formula programs proposed in bill introduced day earlier by Democrat leaders on Appropriations Committee. Biden deems Defense Production Act applicable to manufacturing formula products.

FDA Politics
See All

Business Explore this Topic

Set Alert for Business {Wellness}

Latest From Deals & Wellness

EU Business News: PharmaSGP Makes Record Start, BioGaia Heads To Canada, Ardian Takes Nutripure Stake

Round-up of European consumer health business news: Germany's PharmaSGP breaks sales record in Q1 as acquired brands grow; probiotics player BioGaia plans direct distribution in Canada; and private-equity firm Ardian takes a stake in French e-commerce supplements specialist Nutripure.

Europe Sales & Earnings

Bonafide Women’s Health Acquires SAM-e Formulation With High Bioavailability

Women’s health company acquired patent for SAM-e formulation MSI-195 after innovator's study showed it had nearly three times higher availability than a leading competitor.

Deals Dietary Supplements

EU Business News: Dermapharm Gets Boost From Vitamin D; Sanofi Plans Turkish Launch; Krka Posts Sales RIse

A round-up of European consumer health business news: Dermapharm sees 2021 sales rise on the back of increased vitamin D demand; Sanofi plans to launch Enzymatica's ColdZyme in Turkey; and Slovenia's Krka posts rise in OTC sales.

Business Strategies Deals
See All

Latest From Business Strategies & Wellness

People On The Move: Appointments At Alliance Pharma, Venture Life, Maxwellia

A round-up of the latest European consumer health industry appointments: Alliance Pharma names Jo LeCouilliard as chair; Venture Life hires Paul McGreevy as non-executive chair; and Maxwellia appoints Ian Adamson as a strategic advisor.

Europe Executive Changes

Biden Mandates Prioritizing Supplies For Infant Formula Production Over All Other Uses

Democrats and Republicans vote to approve $28m emergency finding for FDA formula programs proposed in bill introduced day earlier by Democrat leaders on Appropriations Committee. Biden deems Defense Production Act applicable to manufacturing formula products.

FDA Politics

NDI Notification Guidance Deadline Included In Senate Draft Bill For FDA User Fee Programs

HELP Committee Chairwoman Patty Murray, and ranking member Richard Burr also include supplement registration requirement in discussion draft for reauthorizing FDA’s user fee programs for prescription, generic and biosimilar drugs and medical devices.

Dietary Supplements FDA
See All

Latest From Sales & Earnings & Wellness

EU Business News: PharmaSGP Makes Record Start, BioGaia Heads To Canada, Ardian Takes Nutripure Stake

Round-up of European consumer health business news: Germany's PharmaSGP breaks sales record in Q1 as acquired brands grow; probiotics player BioGaia plans direct distribution in Canada; and private-equity firm Ardian takes a stake in French e-commerce supplements specialist Nutripure.

Europe Sales & Earnings

USANA Lowers Guidance After 15% Q1 Sales Drop; Mannatech Reports Nearly $1M Undelivered Goods

Due to uncertainty in COVID-19 landscape in China, USANA adjusted its 2022 fiscal year guidance. Direct seller Mannatech decreased its number of fulfilled orders by 6% in the first quarter.

Companies Sales & Earnings

ChromaDex TV Ads Increase Sales, Customer Base

Tru Niagen sales made up more than 85% of first-quarter total, and TV ads launched in March drove a “dramatic increase” in customers, says CEO Robert Fried.

Sales & Earnings Launches
See All

Latest From Legal Issues & Wellness

Preliminary Remediation Begins On Restarting Formula Production At Abbott Nutrition Plant

Decree imposes steps Abbott must complete before it can begin preparing to restart production, including hiring independent consultant to determine whether facility is compliant with FDA manufacturing and labeling regulations.

FDA Enforcement

US FDA Turns To Temporary Enforcement Discretion For Boosting Infant Formula Supply

FDA launches temporary enforcement discretion on infant formula product to help increase supply in US on same day consent decree announced to allow Abbott to restart production at facility closed since February, prompting ongoing formula shortage. 

FDA Legal Issues

Supplements Mixed With Direct Selling A Recipe Ripe For Cooking US FTC Regulation Violations

Doesn’t take long to find health and wellness product marketers on list of direct sellers or find firms offering those products in the FTC's history of enforcement actions in the sector. 

Dietary Supplements Enforcement
See All

Marketing Explore this Topic

Set Alert for Marketing {Wellness}

Latest From Launches & Wellness

OTC Marketing Awards 2022 Open For Entries

The Oscars of the OTC industry returns for its 27th year, inviting entries from UK consumer health players across 15 categories. This year sees the introduction of a new award to recognize environmentally-friendly OTC innovation.

Innovation Launches

ChromaDex TV Ads Increase Sales, Customer Base

Tru Niagen sales made up more than 85% of first-quarter total, and TV ads launched in March drove a “dramatic increase” in customers, says CEO Robert Fried.

Sales & Earnings Launches

Homeopathic Firm Rebrands As Hyland’s Naturals With Shift To Focus On Supplement Market

Hyland’s Naturals focused for nearly 120 years on providing consumer health products in the pediatric and general wellness categories and is expanding into the women’s health and pet categories. Also will launch more than 20 natural wellness products over the next year.

OTC Drugs Dietary Supplements
See All

Latest From Ad Campaigns & Wellness

OTC Marketing Awards 2022 Open For Entries

The Oscars of the OTC industry returns for its 27th year, inviting entries from UK consumer health players across 15 categories. This year sees the introduction of a new award to recognize environmentally-friendly OTC innovation.

Innovation Launches

ChromaDex TV Ads Increase Sales, Customer Base

Tru Niagen sales made up more than 85% of first-quarter total, and TV ads launched in March drove a “dramatic increase” in customers, says CEO Robert Fried.

Sales & Earnings Launches

Homeopathic Firm Rebrands As Hyland’s Naturals With Shift To Focus On Supplement Market

Hyland’s Naturals focused for nearly 120 years on providing consumer health products in the pediatric and general wellness categories and is expanding into the women’s health and pet categories. Also will launch more than 20 natural wellness products over the next year.

OTC Drugs Dietary Supplements
See All

Latest From Ad Complaints & Wellness

Before Infant Formula Recall, Abbott ‘Closed-Done’ With Investigation Complaint Referencing Death

FDA report on inspection states Abbott and agency “found evidence" of Cronobacter species bacteria in powdered infant formula production environment and firm also identified bacteria in finished powdered formula products. Once Abbott gets FDA clearance to restart production at facility, it will need as much as two months before formula made there reaches stores.

FDA Safety

US FDA Turns To Temporary Enforcement Discretion For Boosting Infant Formula Supply

FDA launches temporary enforcement discretion on infant formula product to help increase supply in US on same day consent decree announced to allow Abbott to restart production at facility closed since February, prompting ongoing formula shortage. 

FDA Legal Issues

US Firm Removed From Warnings About Botanicals ‘Removed’ From Lawful Use In Supplements

FDA retracts warning against Glanbia Performance Nutrition Manufacturing about selling adulterated dietary supplements.

Dietary Supplements FDA
See All
UsernamePublicRestriction

Register